Necrotic Enteritis in Broilers: Etiology, Diagnosis, and Management of Clostridium perfringens Infections
Introduction
Necrotic enteritis (NE) is an economically devastating enteric disease of broiler chickens caused by toxigenic strains of Clostridium perfringens. The disease manifests in acute clinical forms with high mortality and subclinical forms that impair feed conversion and growth performance. Global annual losses attributable to NE are estimated to exceed USD 6 billion, driven by mortality, reduced weight gain, increased feed conversion ratios, and costs associated with treatment and prevention [1, 2]. The disease has gained renewed prominence following the progressive restriction of in-feed antibiotic growth promoters (AGPs) in many jurisdictions, which previously suppressed subclinical infections [3]. This article provides a detailed examination of the etiology, pathogenesis, clinical presentation, diagnostic approaches, and current management strategies for NE in broiler flocks.
Etiology and Bacteriology
Clostridium perfringens is a Gram positive, spore forming, anaerobic, rod shaped bacterium. It is classified into seven toxinotypes (A through G) based on the production of six major toxins: alpha (CPA), beta (CPB), epsilon (ETX), iota (ITX), enterotoxin (CPE), and NetB [4, 5]. Historically, NE was attributed to type A strains producing CPA, but the discovery of the pore forming toxin NetB (necrotizing enteritis B-like toxin) in 2008 established that NetB is the primary virulence factor for NE in poultry [6]. Strains isolated from NE lesions are almost exclusively NetB positive, whereas NetB negative strains are rarely associated with clinical disease [7]. CPA, a phospholipase C that hydrolyzes phosphatidylcholine and sphingomyelin, contributes to mucosal damage but is not sufficient alone to induce NE [8].
Additional virulence factors include a collagen adhesin (CnaA), a sialidase (NanI), and a hyaluronidase (NagL) that facilitate bacterial adherence, mucus degradation, and tissue invasion [9, 10]. The production of these factors is regulated by the VirSR two component regulatory system, which responds to environmental signals such as nutrient availability and quorum sensing [11].
Pathogenesis
The pathogenesis of NE is multifactorial and requires a permissive intestinal environment for C. perfringens proliferation and toxin production. The disease typically occurs in broilers between 2 and 6 weeks of age, with peak incidence around 3 to 4 weeks [12]. Predisposing factors include dietary changes, coccidial infection, immunosuppression, and disruption of the gut microbiota.
Role of Coccidiosis
Coccidiosis caused by Eimeria species is the most important predisposing factor for NE. Eimeria infection damages the intestinal epithelium, providing a protein rich environment and anaerobic conditions favorable for C. perfringens overgrowth [13]. The interaction between coccidiosis and NE is synergistic; coccidial lesions increase intestinal permeability and leakage of plasma proteins, which serve as substrates for bacterial growth [14]. This relationship is discussed in detail in the article on Avian Coccidiosis: Eimeria Species Identification, Commercial Vaccines, and Anticoccidial Resistance in Broiler Flocks.
Dietary Factors
Diets high in animal derived proteins (e.g., fishmeal) and non starch polysaccharides (e.g., wheat, barley, rye) increase the viscosity of intestinal digesta and slow transit time, promoting C. perfringens proliferation [15]. High protein diets provide amino acids and peptides that serve as growth substrates. Conversely, diets containing corn and soybean meal are associated with lower NE incidence [16].
Gut Microbiome Dysbiosis
The intestinal microbiota of healthy broilers suppresses C. perfringens through competitive exclusion, production of short chain fatty acids, and modulation of the immune response. Disruption of this microbiota by AGP withdrawal, stress, or antimicrobial therapy creates a niche for clostridial expansion [17]. The role of the gut microbiome in NE pathogenesis is further explored in the article on Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies.
Toxin Mediated Pathology
NetB is a beta barrel pore forming toxin that inserts into the plasma membrane of host cells, causing osmotic lysis and necrosis [18]. The toxin targets intestinal epithelial cells, enterocytes, and leukocytes. NetB mediated cell death triggers a robust inflammatory response characterized by infiltration of heterophils and macrophages, release of proinflammatory cytokines, and oxidative stress [19]. CPA synergizes with NetB by hydrolyzing membrane phospholipids and activating the arachidonic acid cascade, amplifying tissue damage [20].
Clinical Signs and Necropsy Findings
Clinical Presentation
NE presents in two forms: acute clinical and subclinical. Acute NE is characterized by sudden onset of depression, anorexia, diarrhea (often bloody or mucoid), and a sharp increase in flock mortality, typically reaching 1 to 5 percent per day over 3 to 5 days [21]. Affected birds are lethargic, huddle together, and have ruffled feathers. Morbidity can reach 10 to 40 percent in untreated flocks.
Subclinical NE is more insidious and economically significant. Birds exhibit reduced feed intake, poor weight gain, and increased feed conversion ratios without overt mortality [22]. This form is often undiagnosed and contributes to substantial production losses.
Necropsy Findings
Gross lesions are confined to the small intestine, particularly the jejunum and ileum. The intestinal wall is distended, friable, and covered with a pseudomembrane composed of fibrin, necrotic debris, and bacterial cells [23]. The mucosal surface is hemorrhagic and ulcerated. The lumen contains dark, foul smelling fluid. The liver may be enlarged and congested. Microscopic examination reveals coagulative necrosis of the villi, fibrinoid necrosis of blood vessels, and massive infiltration of heterophils and macrophages [24].
Diagnosis
Definitive diagnosis of NE requires integration of clinical history, necropsy findings, histopathology, and laboratory confirmation of toxigenic C. perfringens.
Histopathology
Histological examination of intestinal sections stained with hematoxylin and eosin reveals characteristic lesions: villus necrosis, fibrin exudation, and Gram positive rod shaped bacteria adherent to the mucosal surface [25]. Immunohistochemistry using antibodies against NetB or CPA can confirm toxin presence in tissue sections.
Bacterial Culture and Isolation
C. perfringens is isolated from intestinal scrapings or liver samples under anaerobic conditions on selective media such as tryptose sulfite cycloserine (TSC) agar or egg yolk agar [26]. Colonies appear black on TSC agar due to sulfite reduction. Identification is confirmed by Gram staining, absence of oxygen tolerance, and biochemical profiling. However, culture alone cannot distinguish toxigenic from non toxigenic strains.
Molecular Detection
PCR based methods are the gold standard for detecting toxin genes. Multiplex PCR panels targeting cpa, netB, cpb, etx, iA, and cpe allow simultaneous toxinotyping [27]. Quantitative real time PCR (qPCR) can quantify C. perfringens load in intestinal contents and correlate bacterial density with lesion severity [28]. Loop mediated isothermal amplification (LAMP) assays targeting netB provide rapid, field deployable detection with sensitivity comparable to PCR [29].
Serological Assays
Enzyme linked immunosorbent assays (ELISAs) for detecting NetB antibodies in serum or egg yolk are used for flock level surveillance and vaccine response monitoring [30]. The principles of these assays are analogous to those described for Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus.
Diagnostic Algorithm
The following Mermaid diagram outlines a diagnostic workflow for NE in broiler flocks.
flowchart TD
A[Clinical suspicion: depression, diarrhea, mortality spike], > B[Necropsy examination]
B, > C{Gross lesions present?}
C, >|Yes| D[Collect intestinal and liver samples]
C, >|No| E[Consider subclinical NE or other enteropathies]
D, > F[Histopathology]
D, > G[Anaerobic culture on TSC agar]
D, > H[Multiplex PCR for toxin genes]
F, > I[Confirm villus necrosis and Gram positive rods]
G, > J[Isolate C. perfringens colonies]
H, > K[Detect netB and cpa]
I & J & K, > L[Definitive diagnosis of NE]
L, > M[Antimicrobial susceptibility testing if needed]
Management and Control
Control of NE relies on an integrated approach combining biosecurity, nutritional management, vaccination, and judicious use of antimicrobial alternatives.
Biosecurity and Management
Strict biosecurity protocols reduce environmental contamination with C. perfringens spores. Litter management is critical; wet, caked litter promotes sporulation and re-infection [31]. Adequate ventilation, stocking density control, and all in/all out production systems minimize pathogen load. Cleaning and disinfection between flocks should include sporicidal agents such as chlorine dioxide or peracetic acid [32].
Nutritional Strategies
Dietary modifications can reduce NE risk. Reducing dietary crude protein levels and replacing animal derived proteins with plant based alternatives limits substrate availability for C. perfringens [33]. Supplementation with exogenous enzymes (e.g., xylanases, beta glucanases) reduces digesta viscosity in wheat or barley based diets [34]. Organic acids (e.g., butyric acid, formic acid) lower intestinal pH and inhibit clostridial growth [35].
Antimicrobial Alternatives
The withdrawal of AGPs has driven research into alternatives that modulate the gut microbiota and immune response.
Probiotics and Direct Fed Microbials
Bacillus species (e.g., Bacillus subtilis, Bacillus licheniformis) are the most widely studied probiotics for NE control. These spore forming bacteria produce antimicrobial peptides (bacteriocins), compete for adhesion sites, and stimulate host immunity [36]. Lactobacillus and Enterococcus strains also show efficacy by producing lactic acid and reducing intestinal pH [37].
Prebiotics and Synbiotics
Mannan oligosaccharides (MOS), fructooligosaccharides (FOS), and inulin selectively stimulate beneficial bacteria such as Lactobacillus and Bifidobacterium, thereby suppressing C. perfringens [38]. Synbiotics (combinations of probiotics and prebiotics) provide synergistic effects.
Bacteriophages
Phage therapy targeting C. perfringens has shown promise in experimental models. Phages specific to NetB producing strains can lyse bacteria in the intestinal lumen and reduce lesion scores [39]. Challenges include phage stability, delivery, and the potential for bacterial resistance.
Antimicrobial Peptides
Host defense peptides (e.g., defensins, cathelicidins) and synthetic analogs exhibit direct bactericidal activity against C. perfringens and modulate inflammatory responses [40]. Their clinical application remains limited by production costs and stability.
Plant Derived Compounds
Essential oils (e.g., thymol, carvacrol, cinnamaldehyde) and plant extracts (e.g., garlic, oregano, turmeric) disrupt bacterial cell membranes and inhibit toxin production [41]. Their efficacy is variable and dose dependent.
Vaccination
Vaccination is a key component of long term NE control. Both live and toxoid vaccines have been developed.
Live Vaccines
Live attenuated C. perfringens strains administered orally or via drinking water induce mucosal immunity. A commercially available live vaccine containing a NetB producing type A strain has demonstrated efficacy in reducing NE lesions and mortality [42].
Toxoid Vaccines
Inactivated toxoid vaccines containing NetB and CPA toxoids are administered parenterally to breeder flocks to confer passive immunity to progeny via maternal antibodies [43]. Maternal antibodies protect chicks during the first 2 to 3 weeks of life, the critical window for NE susceptibility.
Recombinant Vaccines
Subunit vaccines based on recombinant NetB, CPA, and other conserved antigens (e.g., CnaA, NanI) are under development. These vaccines aim to induce broad protection against multiple C. perfringens strains [44].
Antimicrobial Therapy
In acute outbreaks, therapeutic antimicrobials are necessary. Water soluble agents such as amoxicillin, bacitracin methylene disalicylate, lincomycin, and tylosin are commonly used [45]. Antimicrobial susceptibility testing is recommended to guide selection and monitor resistance trends. The emergence of antimicrobial resistance in C. perfringens isolates, particularly to tetracyclines and macrolides, is a growing concern [46].
Future Directions
Advances in genomics and computational biology are enabling a deeper understanding of C. perfringens population structure and virulence evolution. Whole genome sequencing and comparative genomics have identified novel putative virulence factors and antimicrobial resistance determinants [47]. Metagenomic analysis of the broiler gut microbiome is revealing microbial signatures associated with NE resistance [48]. These insights will inform the development of next generation probiotics, phage cocktails, and precision vaccines.
The application of biological foundation models for predicting host pathogen interactions and vaccine target identification is an emerging frontier [49]. Such approaches may accelerate the design of broadly protective vaccines against NE.
Conclusion
Necrotic enteritis remains a major challenge for the global broiler industry. The disease is driven by NetB producing C. perfringens type G strains, with pathogenesis dependent on predisposing factors including coccidiosis, diet, and gut microbiome disruption. Accurate diagnosis requires integration of clinical, pathological, and molecular methods. Sustainable control relies on a multifaceted strategy combining biosecurity, nutritional management, vaccination, and antimicrobial alternatives. Continued research into host pathogen interactions and microbial ecology will be essential for developing effective, antibiotic free control programs.
References
[1] Van der Sluis W. Clostridial enteritis is an often underestimated problem. World Poultry. 2000;16(7):42-43.
[2] Wade B, Keyburn A. The true cost of necrotic enteritis. World Poultry. 2015;31(2):16-17.
[3] Gaucher ML, Quessy S, Letellier A, et al. Impact of antimicrobial growth promoter withdrawal on broiler gut microbiota and necrotic enteritis. Avian Pathol. 2015;44(4):282-290.
[4] Rood JI, Adams V, Lacey J, et al. Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe. 2018;53:5-10.
[5] Uzal FA, Freedman JC, Shrestha A, et al. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. 2014;9(3):361-377.
[6] Keyburn AL, Boyce JD, Vaz P, et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog. 2008;4(2):e26.
[7] Keyburn AL, Yan XX, Bannam TL, et al. Association between avian necrotic enteritis and Clostridium perfringens strains expressing NetB toxin. Vet Res. 2010;41(2):21.
[8] Keyburn AL, Bannam TL, Moore RJ, Rood JI. NetB, a pore-forming toxin from necrotic enteritis strains of Clostridium perfringens. Toxins. 2010;2(7):1913-1927.
[9] Wade B, Keyburn AL, Seemann T, et al. The adherent abilities of Clostridium perfringens strains are critical for the pathogenesis of avian necrotic enteritis. Vet Microbiol. 2016;197:53-61.
[10] Li J, McClane BA. The sialidases of Clostridium perfringens type D strain CN3718 differ in their properties and sensitivities to inhibitors. Infect Immun. 2014;82(5):2014-2024.
[11] Ohtani K, Shimizu T. Regulation of toxin production in Clostridium perfringens. Toxins. 2015;7(6):2251-2270.
[12] McDevitt RM, Brooker JD, Acamovic T, Sparks NHC. Necrotic enteritis; a continuing challenge for the poultry industry. Worlds Poult Sci J. 2006;62(2):221-247.
[13] Williams RB. Intercurrent coccidiosis and necrotic enteritis of chickens: rational, integrated disease management by maintenance of gut integrity. Avian Pathol. 2005;34(3):159-180.
[14] Collier CT, Hofacre CL, Payne AM, et al. Coccidia-induced mucogenesis promotes the onset of necrotic enteritis by supporting Clostridium perfringens growth. Vet Immunol Immunopathol. 2008;122(1-2):104-115.
[15] Kaldhusdal M, Hofshagen M. Barley inclusion and avoparcin supplementation in broiler diets. 2. Clinical, pathological, and bacteriological findings in a mild form of necrotic enteritis. Poult Sci. 1992;71(7):1145-1153.
[16] Drew MD, Syed NA, Goldade BG, et al. Effects of dietary protein source and level on intestinal populations of Clostridium perfringens in broiler chickens. Poult Sci. 2004;83(3):414-420.
[17] Stanley D, Hughes RJ, Moore RJ. Microbiota of the chicken gastrointestinal tract: influence on health, productivity and disease. Appl Microbiol Biotechnol. 2014;98(10):4301-4310.
[18] Savva CG, Fernandes da Costa SP, Bokori-Brown M, et al. Molecular architecture and functional analysis of NetB, a pore-forming toxin from Clostridium perfringens. J Biol Chem. 2013;288(5):3512-3522.
[19] Lee KW, Lillehoj HS, Jeong W, et al. Avian necrotic enteritis: experimental models, host immunity, and vaccines. Avian Pathol. 2011;40(4):343-352.
[20] Titball RW. Bacterial phospholipases C. Microbiol Rev. 1993;57(2):347-366.
[21] Long JR, Pettit JR, Barnum DA. Necrotic enteritis in broiler chickens. II. Pathology and proposed pathogenesis. Can J Comp Med. 1974;38(4):467-474.
[22] Skinner JT, Bauer S, Young V, et al. An economic analysis of the impact of subclinical (mild) necrotic enteritis in broiler chickens. Avian Dis. 2010;54(4):1237-1240.
[23] Helmboldt CF, Bryant ES. The pathology of necrotic enteritis in domestic fowl. Avian Dis. 1971;15(4):775-780.
[24] Olkowski AA, Wojnarowicz C, Chirino-Trejo M, Drew MD. Responses of broiler chickens to oral challenge with Clostridium perfringens isolates from cases of necrotic enteritis. Res Vet Sci. 2006;80(1):99-108.
[25] Cooper KK, Songer JG. Necrotic enteritis in chickens: a paradigm of enteric infection by Clostridium perfringens type A. Anaerobe. 2009;15(1-2):55-60.
[26] Harmon SM, Kautter DA, Peeler JT. Comparison of media for the enumeration of Clostridium perfringens. Appl Environ Microbiol. 1971;21(5):922-927.
[27] Gholamiandehkordi AR, Timbermont L, Lanckriet A, et al. Quantification of gut lesions in a subclinical necrotic enteritis model. Avian Pathol. 2007;36(5):375-382.
[28] Timbermont L, Lanckriet A, Gholamiandehkordi AR, et al. Origin of Clostridium perfringens isolates determines the ability to induce necrotic enteritis in broilers. Vet Microbiol. 2009;135(3-4):332-339.
[29] Yang Q, Wang S, Ji F, et al. Development and application of a loop-mediated isothermal amplification assay for rapid detection of Clostridium perfringens netB gene. J Microbiol Methods. 2016;127:1-5.
[30] Lanckriet A, Timbermont L, Eeckhaut V, et al. Variable protection after vaccination of broiler chickens against necrotic enteritis using a recombinant NetB toxoid. Avian Pathol. 2010;39(5):329-334.
[31] Craven SE, Stern NJ, Cox NA, et al. Cecal carriage of Clostridium perfringens in broiler chickens given Mucosal Starter Culture. Avian Dis. 1999;43(3):484-490.
[32] Stringfellow K, Caldwell D, Lee J, et al. Evaluation of disinfectants for the inactivation of Clostridium perfringens spores. J Appl Poult Res. 2009;18(3):510-516.
[33] Palliyeguru MW, Rose SP, Mackenzie AM. Effect of dietary protein concentrates on the incidence of subclinical necrotic enteritis and growth performance of broiler chickens. Poult Sci. 2010;89(1):34-43.
[34] Choct M, Hughes RJ, Bedford MR. Effects of a xylanase on individual bird variation, starch digestion throughout the intestine, and ileal and caecal volatile fatty acid production in chickens fed wheat. Br Poult Sci. 1999;40(3):419-422.
[35] Van Immerseel F, Fievez V, de Buck J, et al. Microencapsulated short-chain fatty acids in feed modify colonization and invasion early after infection with Salmonella enteritidis in young chickens. Poult Sci. 2004;83(1):69-74.
[36] La Ragione RM, Woodward MJ. Competitive exclusion by Bacillus subtilis spores of Salmonella enterica serotype Enteritidis and Clostridium perfringens in young chickens. Vet Microbiol. 2003;94(3):245-256.
[37] Hofacre CL, Froyman R, Gautrias B, et al. Use of Aviguard and other intestinal bioproducts in experimental Clostridium perfringens-associated necrotizing enteritis in broiler chickens. Avian Dis. 1998;42(3):579-584.
[38] Spring P, Wenk C, Dawson KA, Newman KE. The effects of dietary mannanoligosaccharides on cecal parameters and the concentrations of enteric bacteria in the ceca of Salmonella-challenged broiler chicks. Poult Sci. 2000;79(2):205-211.
[39] Miller RW, Skinner EJ, Sulakvelidze A, et al. Bacteriophage therapy for control of necrotic enteritis in broiler chickens. Avian Dis. 2010;54(1):33-40.
[40] van Dijk A, Veldhuizen EJ, Haagsman HP. Avian defensins. Vet Immunol Immunopathol. 2008;124(1-2):1-18.
[41] Mitsch P, Zitterl-Eglseer K, Kohler B, et al. The effect of two different blends of essential oil components on the proliferation of Clostridium perfringens in the intestines of broiler chickens. Poult Sci. 2004;83(4):669-675.
[42] Thompson DR, Parreira VR, Kulkarni RR, Prescott JF. Live attenuated vaccine-based control of necrotic enteritis in broiler chickens. Vet Microbiol. 2006;113(1-2):25-34.
[43] Lovland A, Kaldhusdal M, Redhead K, et al. Maternal vaccination against subclinical necrotic enteritis in broilers. Avian Pathol. 2004;33(1):83-92.
[44] Jiang Y, Kulkarni RR, Parreira VR, Prescott JF. Immunization of broiler chickens against Clostridium perfringens-induced necrotic enteritis using a recombinant NetB protein. Vet Microbiol. 2009;137(1-2):180-185.
[45] Prescott JF, Sivendra R, Barnum DA. The use of bacitracin in the prevention and treatment of experimentally-induced necrotic enteritis in the chicken. Can Vet J. 1978;19(7):181-183.
[46] Martel A, Devriese LA, Cauwerts K, et al. Susceptibility of Clostridium perfringens strains from broiler chickens to antibiotics and anticoccidials. Avian Pathol. 2004;33(1):3-7.
[47] Lacey JA, Allnutt TR, Vezina B, et al. Whole genome analysis reveals the diversity and evolutionary relationships of necrotic enteritis-causing Clostridium perfringens strains. BMC Genomics. 2018;19(1):379.
[48] Stanley D, Keyburn AL, Ford SE, Moore RJ. The intestinal microbiome of broiler chickens with necrotic enteritis. Vet Microbiol. 2012;159(3-4):485-490.
[49] Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022;23(1):40-55.
[50] Timbermont L, Haesebrouck F, Ducatelle R, Van Immerseel F. Necrotic enteritis in broilers: an updated review on the pathogenesis. Avian Pathol. 2011;40(4):341-347.